Literature DB >> 22045098

A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.

Kar Neng Lai1, Man Fai Lam, Joseph C K Leung, Loretta Y Chan, Christopher W K Lam, Iris H S Chan, Hoi Wong Chan, Chun Sang Li, Sunny S H Wong, Yiu Wing Ho, Au Cheuk, Matthew K L Tong, Sydney C W Tang.   

Abstract

OBJECTIVE: Although peritoneal dialysis (PD) is a widely accepted form of renal replacement therapy, concerns remain regarding the bioincompatible nature of standard PD fluid (PDF). Short-term studies of new biocompatible PDFs low in glucose degradation products (GDPs) reveal divergent results with respect to peritoneal integrity.
METHODS: We studied 125 patients on maintenance PD who were assigned, by simple randomization, to receive either conventional or low-GDP PDF at PD initiation. Parameters of dialysis adequacy and peritoneal transport of small solutes were determined at initiation and after a period of maintenance PD at the time when serum and overnight effluent dialysate were simultaneously collected and assayed for various cytokines, chemokines, adipokines, and cardiac biomarkers. All patients were further followed prospectively for an average of 15 months from the day of serum and effluent collection to determine patient survival and cardiovascular events.
RESULTS: Patients treated with conventional or low-GDP PDF were matched for sex, age, duration of dialysis, dialysis adequacy, and incidence of cardiovascular disease or diabetes. After an average of 2.3 years of PD treatment, the weekly total and peritoneal creatinine clearance, and the total and peritoneal Kt/V were comparable in the groups. However, urine output was higher in patients using low-GDP PDF despite there having been no difference between the groups at PD initiation. Patients using low-GDP PDF also experienced a slower rate of decline of residual glomerular filtration and urine output than did patients on conventional PDF. Compared with serum concentrations, effluent concentrations of tumor necrosis factor α, hepatocyte growth factor, macrophage migration inhibitory factor, interleukins 8 and 6, C-reactive protein, and leptin were found to be higher in both groups of patients after long-term PD, suggesting that the peritoneal cavity was the major source of those mediators. Compared with patients on low-GDP PDF, patients on conventional fluid showed elevated leptin and reduced adiponectin levels in serum and effluent. The effluent concentration of interleukin 8 was significantly lower in patients using low-GDP PDF. The survival rate and incidence of cardiovascular complications did not differ between these groups after maintenance PD for an average of 3.6 years.
CONCLUSIONS: It appears that low-GDP PDF results in an improvement of local peritoneal homeostasis through a reduction of chronic inflammatory status in the peritoneum.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045098      PMCID: PMC3525436          DOI: 10.3747/pdi.2010.00176

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  45 in total

Review 1.  Glucose degradation products in peritoneal dialysis: from bench to bedside.

Authors:  Achim Jörres
Journal:  Kidney Blood Press Res       Date:  2003       Impact factor: 2.687

2.  Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.

Authors:  Jernej Pajek; Radoslav Kveder; Andrej Bren; Andrej Gucek; Maja Bucar; Andrej Skoberne; Jacek Waniewski; Bengt Lindholm
Journal:  Nephrol Dial Transplant       Date:  2008-12-09       Impact factor: 5.992

3.  Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.

Authors:  K Honda; K Nitta; S Horita; W Yumura; H Nihei; R Nagai; K Ikeda; S Horiuchi
Journal:  Nephrol Dial Transplant       Date:  1999-06       Impact factor: 5.992

4.  Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.

Authors:  Ho Yung Lee; Hoon Young Choi; Hyeong Cheon Park; Bo Jeung Seo; Jun Young Do; Sung Ro Yun; Hyun Yong Song; Yeong Hoon Kim; Yong-Lim Kim; Dae Joong Kim; Yong Soo Kim; Moon Jae Kim; Sug Kyun Shin
Journal:  Nephrol Dial Transplant       Date:  2006-09-06       Impact factor: 5.992

5.  Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).

Authors:  Ho Yung Lee; Hyeong Cheon Park; Bo Jeung Seo; Jun Young Do; Sung Ro Yun; Hyun Yong Song; Yeong Hoon Kim; Yong Lim Kim; Dae Joong Kim; Yong Soo Kim; Curie Ahn; Moon Jae Kim; Sug Kyun Shin
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

6.  Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function.

Authors:  S L S Fan; T Pile; S Punzalan; M J Raftery; M M Yaqoob
Journal:  Kidney Int       Date:  2007-10-03       Impact factor: 10.612

7.  Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis.

Authors:  K D Nolph; H L Moore; Z J Twardowski; R Khanna; B Prowant; M Meyer; L Ponferrada
Journal:  ASAIO J       Date:  1992 Jul-Sep       Impact factor: 2.872

Review 8.  Body composition analysis techniques in adult and pediatric patients: how reliable are they? How useful are they clinically?

Authors:  Graham Woodrow
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

9.  Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease.

Authors:  Seung Hyeok Han; Hoon Young Choi; Dong Ki Kim; Sung Jin Moon; Jung Eun Lee; Tae Hyun Yoo; Beom Seok Kim; Shin-Wook Kang; Kyu Hun Choi; Ho Yung Lee; Dae-Suk Han
Journal:  Am J Nephrol       Date:  2008-08-22       Impact factor: 3.754

10.  Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis.

Authors:  R W van Olden; R T Krediet; D G Struijk; L Arisz
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

View more
  15 in total

1.  Trials (and tribulations) of biocompatible peritoneal dialysis fluids.

Authors:  David W Johnson; Yeoungjee Cho; Fiona G Brown
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

2.  Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.

Authors:  Susan Yung; Sing Leung Lui; Chris K F Ng; Andrew Yim; Maggie K M Ma; Kin Yee Lo; Chik Cheung Chow; Kwok Hong Chu; Wai Leung Chak; Man Fai Lam; Chun Yu Yung; Terence P S Yip; Sunny Wong; Colin S O Tang; Flora S K Ng; Tak Mao Chan
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

Review 3.  Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.

Authors:  Seychelle Yohanna; Ali M A Alkatheeri; Scott K Brimble; Brendan McCormick; Arthur Iansavitchous; Peter G Blake; Arsh K Jain
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237

4.  Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids.

Authors:  Monika Lichodziejewska-Niemierko; Michał Chmielewski; Maria Dudziak; Alicja Ryta; Bolesław Rutkowski
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

Review 5.  Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.

Authors:  Eun-Young Seo; Sook Hee An; Jang-Hee Cho; Hae Sun Suh; Sun-Hee Park; Hyesun Gwak; Yong-Lim Kim; Hunjoo Ha
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

6.  Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Elaine M Pascoe; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

7.  Dialysis Duration and Glucose Exposure Amount Do Not Increase Mortality Risk in Peritoneal Dialysis Patients: A Population-Based Cohort Study From 2004 to 2012.

Authors:  Pei-Yu Wu; Ming-Yen Lin; Shang-Jyh Hwang; Yi-Wen Chiu
Journal:  Front Med (Lausanne)       Date:  2022-06-28

8.  Transcriptional patterns in peritoneal tissue of encapsulating peritoneal sclerosis, a complication of chronic peritoneal dialysis.

Authors:  Fabian R Reimold; Niko Braun; Zsuzsanna K Zsengellér; Isaac E Stillman; S Ananth Karumanchi; Hakan R Toka; Joerg Latus; Peter Fritz; Dagmar Biegger; Stephan Segerer; M Dominik Alscher; Manoj K Bhasin; Seth L Alper
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Biocompatible peritoneal dialysis fluids: clinical outcomes.

Authors:  Yeoungjee Cho; Sunil V Badve; Carmel M Hawley; Kathryn Wiggins; David W Johnson
Journal:  Int J Nephrol       Date:  2012-11-28

10.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.